Reduced α-dystroglycan expression correlates with shortened patient survival in pancreatic cancer.

[1]  H. Friess,et al.  Ex vivo chemosensitivity testing and gene expression profiling predict response towards adjuvant gemcitabine treatment in pancreatic cancer , 2008, British Journal of Cancer.

[2]  H. Friess,et al.  Cannabinoids in pancreatic cancer: Correlation with survival and pain , 2008, International journal of cancer.

[3]  G. Rossi,et al.  Dystroglycan expression is reduced during prostate tumorigenesis and is regulated by androgens in prostate cancer cells , 2007, Journal of cellular physiology.

[4]  H. Friess,et al.  Surgical treatment of pancreatic cancer: the role of adjuvant and multimodal therapies. , 2007, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[5]  Jürgen Weitz,et al.  Surgery Insight: surgical management of pancreatic cancer , 2007, Nature Clinical Practice Oncology.

[6]  Christoph Michalski,et al.  Pancreatic Cancer: From Bench to 5-Year Survival , 2006, Pancreas.

[7]  T. Petrucci,et al.  Altered expression of alpha-dystroglycan subunit in human gliomas , 2006, Cancer biology & therapy.

[8]  H. Friess,et al.  Loss of BNIP3 expression is a late event in pancreatic cancer contributing to chemoresistance and worsened prognosis , 2005, Oncogene.

[9]  D. Górecki,et al.  Dystroglycan complex in cancer. , 2004, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[10]  G. Rossi,et al.  Dystroglycan expression is frequently reduced in human breast and colon cancers and is associated with tumor progression. , 2003, The American journal of pathology.

[11]  K. Campbell,et al.  A role for dystroglycan in epithelial polarization: loss of function in breast tumor cells. , 2002, Cancer research.

[12]  A. Tőkés,et al.  Extracellular matrix components in breast carcinomas. , 2002, Seminars in cancer biology.

[13]  S. Carbonetto,et al.  Dystroglycan Is Not Required for Localization of Dystrophin, Syntrophin, and Neuronal Nitric-oxide Synthase at the Sarcolemma but Regulates Integrin α7B Expression and Caveolin-3 Distribution* , 2002, The Journal of Biological Chemistry.

[14]  K. Campbell,et al.  Reduced expression of dystroglycan in breast and prostate cancer. , 2001, Human pathology.

[15]  R H Hruban,et al.  Pancreatic Intraepithelial Neoplasia: A New Nomenclature and Classification System for Pancreatic Duct Lesions , 2001, The American journal of surgical pathology.

[16]  A. Cittadini,et al.  Anomalous dystroglycan in carcinoma cell lines , 2000, FEBS letters.

[17]  Andrea Brancaccio,et al.  Characterization of the β-Dystroglycan–Growth Factor Receptor 2 (Grb2) Interaction☆ , 2000 .

[18]  K. Campbell,et al.  Biosynthesis of dystroglycan: processing of a precursor propeptide , 2000, FEBS letters.

[19]  K. Campbell,et al.  Biochemical Characterization of the Epithelial Dystroglycan Complex* , 1999, The Journal of Biological Chemistry.

[20]  D. Winchester,et al.  Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985-1995, using the National Cancer Database. , 1999, Journal of the American College of Surgeons.

[21]  K. Campbell,et al.  A Role for Dystroglycan in Basement Membrane Assembly , 1998, Cell.

[22]  K. Daniels,et al.  Dystroglycan is essential for early embryonic development: disruption of Reichert's membrane in Dag1-null mice. , 1997, Human molecular genetics.

[23]  K. Campbell,et al.  Dystroglycan: an extracellular matrix receptor linked to the cytoskeleton. , 1996, Current opinion in cell biology.

[24]  O. Ibraghimov-Beskrovnaya,et al.  Non-muscle alpha-dystroglycan is involved in epithelial development , 1995, The Journal of cell biology.

[25]  K. Campbell,et al.  SH3 Domain-mediated Interaction of Dystroglycan and Grb2(*) , 1995, The Journal of Biological Chemistry.

[26]  O. Ibraghimov-Beskrovnaya,et al.  Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix , 1992, Nature.

[27]  A. Cittadini,et al.  Aberrant expression of alpha-dystroglycan in cervical and vulvar cancer. , 2006, Gynecologic oncology.